Diffusivity changes in bevacizumab-responding and -refractory meningioma
Crossref DOI link: https://doi.org/10.1007/s00234-017-1923-y
Published Online: 2017-09-14
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Roelcke, Ulrich
Berberat, Jatta
Mamot, Christoph
Remonda, Luca
License valid from 2017-09-14